| 11732266 |
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof |
Yang Li, Jun Zhang, Oliver HOMANN, Leslie P. Miranda, Justin K. MURRAY +5 more |
2023-08-22 |
| 10870856 |
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof |
Yang Li, Jun Zhang, Oliver HOMANN, Leslie P. Miranda, Justin K. MURRAY +4 more |
2020-12-22 |
| 8758994 |
CDK9 as modifier of the IGF pathway and methods of use |
Mark E. Maxwell, Timothy S. Heuer, Lynn Margaret Bjerke |
2014-06-24 |
| 8288119 |
PGDS as modifiers of the PTEN pathway and methods of use |
Chunyan Song, Lynn Margaret Bjerke |
2012-10-16 |
| 7927872 |
ALDOs as modifiers of the IGF pathway and methods of use |
Mark E. Maxwell, Timothy S. Heuer, Benjamin C. Hitz |
2011-04-19 |
| 6630297 |
Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target |
Kevin Patrick Keegan, Thomas Stout, David Matthews, Alison Joly |
2003-10-07 |
| 6515109 |
Human ECT2 polypeptide |
Kevin Patrick Keegan, Thomas Stout, David Matthews, Alison Joly |
2003-02-04 |